# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-051094
Filing Date
2021-04-16
Accepted
2021-04-16 08:04:01
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm2112664d1_defa14a.htm | DEFA14A | 22674
2 | GRAPHIC | tm2112664d1_defa14aimg001.jpg | GRAPHIC | 556403
3 | GRAPHIC | tm2112664d1_defa14aimg002.jpg | GRAPHIC | 616453
| Complete submission text file | 0001104659-21-051094.txt |  | 1639376

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 21830136
SIC: 2834 Pharmaceutical Preparations